What is CPM LabFab?
CPM LabFab, Inc. operates at the intersection of industrial manufacturing and scientific infrastructure. The company specializes in the fabrication of modular laboratories, offering a streamlined alternative to conventional building methods. Through its proprietary product lines, including the MiniExpress Lab, Express Lab, and RapidLab series, the firm delivers functional, cost-effective, and rapidly deployable research environments.
By prioritizing quality materials and modular design, CPM LabFab addresses the critical pain points of organizations requiring immediate laboratory capacity. Their market position is defined by a unique value proposition: reducing the time-to-market for research facilities while maintaining rigorous standards for safety and utility. This approach has allowed the company to serve a diverse clientele, ranging from academic institutions to private sector research entities, effectively bridging the gap between complex facility requirements and efficient project execution.
How much funding has CPM LabFab raised?
CPM LabFab has raised a total of $129K across 1 funding round:
Debt
$129K
Debt (2021): $129K with participation from PPP
Key Investors in CPM LabFab
PPP
Public-Private Partnership
What's next for CPM LabFab?
With the recent influx of capital, CPM LabFab is poised to enter a new phase of growth, focusing on scaling its manufacturing capacity and enhancing its product delivery logistics. The strategic deployment of these funds will likely target the optimization of their supply chain and the expansion of their service offerings to accommodate larger, more complex facility requirements.
As the company transitions from its current stage to a more mature operational model, the focus will shift toward market penetration and the potential integration of advanced smart-lab technologies. By leveraging its established reputation for speed and reliability, CPM LabFab is well-equipped to capture a larger share of the laboratory infrastructure market, ensuring that it remains a preferred partner for organizations seeking to modernize their research capabilities without the delays associated with traditional construction.
